| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Revenue | $958.3M | +25.0% |
| Cost of Revenue | $186.4M | +12.8% |
| Gross Profit | $771.9M | +28.3% |
| R&D Expense | $234.1M | +8.8% |
| SG&A Expense | $147.5M | +14.5% |
| Operating Income | -$120.3M | +45.7% |
| Pre-tax Income | -$96.1M | +54.8% |
| Income Tax | $8.5M | +198.0% |
| Net Income | -$104.6M | +51.5% |
| EPS (Basic) | -$0.78 | +53.0% |
| EPS (Diluted) | -$0.78 | +53.0% |
| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $282.1M | +26.4% |
| Short-term Investments | $346.7M | +48.7% |
| Accounts Receivable | $238.7M | +20.2% |
| Current Assets | $931.9M | +31.2% |
| Total Assets | $1.34B | +20.5% |
| Current Liabilities | $695.9M | +21.1% |
| Total Liabilities | $731.6M | +17.1% |
| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $157.9M | +569.3% |
| Capital Expenditures | $2.6M | -58.2% |
| Investing Cash Flow | -$113.7M | +56.9% |
| Financing Cash Flow | $14.5M | +3.3% |
| Free Cash Flow | $155.3M | +790.0% |
| Stockholders' Equity |
| $605.9M |
| +24.7% |